Key Takeaways FDA-Cleared First At-Home Brain Stimulation Device for Depression The U.S. Food and Drug Administration cleared the first prescription, at-home brain stimulation device for the treatment of depression in Dec. 2025, marking a significant milestone in the evolution of technology-enabled mental healthcare. The device, Flow Neuroscience’s FL-100 headset, uses transcranial direct current stimulation (tDCS) […]
